Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Vaccination
Vaccination in horses involves the administration of antigenic material to stimulate an immune response, providing protection against specific infectious diseases. This process is a key component of preventive equine healthcare, aiming to reduce the incidence and severity of illnesses such as equine influenza, tetanus, and West Nile virus. Vaccines can be administered via various routes and may contain live attenuated, inactivated, or subunit components. The immune response elicited by vaccination helps in the development of immunological memory, enabling horses to respond more effectively upon exposure to the actual pathogen. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in equine populations.
Antibody kinetics against tetanus toxoid before and after primary vaccination of foals. Vaccination recommendations for foals against Clostridium tetani vary. Available studies assessing foal immune responses, maternal antibody interference, or individual variation often used small foal numbers. Objective: To quantify antibody responses after tetanus vaccination in foals and explore associations with passively transferred tetanus antibodies. Methods: Longitudinal cohort study. Methods: Sixty-two Warmblood foals from a single stud farm were followed from birth to 360 days of age. Foals received tetanus vaccinations at day 180 (d180) and d220 of life. Serum samples were collected...
Differential Serum Cytokine Profiles in Aborting and Subclinically Infected Pregnant Mares with Equine Herpesvirus Type 1. Equine herpesvirus type 1 (EHV-1) is a major cause of reproductive loss in mares. This cross-sectional field study evaluated serum concentrations of interleukin-2 (IL-2), interleukin-10 (IL-10), interferon-alpha (IFN-α), and interferon-gamma (IFN-γ), together with the IL-10/IL-2 and IFN-γ/IL-10 ratios, in 26 vaccinated pregnant Thoroughbred mares. The analytical cohort comprised healthy, EHV-1 PCR-negative mares (HM, n = 10), EHV-1 PCR-positive mares sampled within 4 h after fetal expulsion at approximately the sixth month of gestation (AM, n = 9), and EHV-1 PCR-positive pregnant mares with...
Factors associated with equine influenza during the 2025 outbreak in a draft horse population at the Obihiro Racecourse, Japan. In April 2025, equine influenza re-emerged in Japan for the first time in 17 years, resulting in an outbreak at a horse racecourse for Ban'ei racing, a unique form of horse racing in which draft horses pull heavy sleds. This study aimed to describe the epidemiological characteristics of the outbreak and identify individual- and management-level factors associated with equine influenza cases in order to develop improved control programs. A retrospective analysis was conducted using clinical records reported to the racecourse authority between April 21 and June 18, 2025. Cases were defined based...
Molecular detection of African horse sickness virus from selected areas in Ethiopia. Equines are vital to global economies and support millions of livelihoods. However, their productivity and welfare are severely hindered by infectious diseases such as African Horse Sickness, which causes major socio-economic losses in Ethiopia. A cross-sectional study was conducted from November 2022 to May 2023 to isolate and detect African horse sickness virus in equines across epidemic areas of Ethiopia. In total, 30 blood samples and 2 tissue representative specimens were aseptically collected from clinically sick and recently dead animals and transported under cold chain to the National ...
Longitudinal and spatial declines in equine Hendra virus vaccination despite continued risk. Hendra virus is an emerging zoonosis endemic to Australia with high fatality of infection in horses and humans. The role of infected domestic horses as amplifying bridge hosts for onward transmission to humans led to the creation of an equine vaccine as a One Health solution against spillover. Despite the risk this disease represents, previously reported equine vaccination rates were low. This study explored vaccination trends between 2012 and 2023 at fine spatial scales and identified demographic and ecological predictors of vaccination against emerging zoonoses. Over 1 million doses of Equiv...
Seroprevalence and risk factors of African horse sickness in equines in central Gondar, Ethiopia. African horse sickness is a severe vector-borne viral disease of equines, associated with high mortality and substantial economic losses. In Ethiopia, where equines are essential for transport and agriculture, the disease remains endemic, yet epidemiological data are limited in many areas. This study aimed to estimate the seroprevalence of African horse sickness virus (AHSV) and describe variation in seropositivity across selected factors in equines in the Central Gondar Zone, Ethiopia. A cross-sectional study was conducted from December 2024 to August 2025, during which 384 serum samples were...
[New drugs for horses and production animals in 2025]. In 2025, no novel pharmaceutical agents for horses and farm animals were introduced to the German veterinary drug market; however, the use of 2 existing active ingredients was expanded to include additional animal species. A dexamethasone preparation is now approved for use in goats, and a new product containing sodium salicylate for chickens was introduced. Oxalic acid dihydrate is now available as an impregnated strip for contact treatment. In the field of immunological veterinary medicines, a vaccine against epizootic hemorrhagic disease virus in cattle was approved for the first time. In a...
Intermittent shedding dynamics of EHV-1 across biological matrices during a natural outbreak linked to international equestrian events. Equine herpesvirus type 1 (EHV-1) outbreaks associated with international equestrian events have demonstrated the capacity of this virus for rapid transboundary dissemination. However, detailed longitudinal data integrating viral shedding across multiple biological matrices within the same animals during naturally occurring outbreaks remain limited. In this study, ten horses hospitalized during a naturally occurring EHV-1 outbreak linked to an international jumping competition were monitored for 10-12 days, from which 306 nasal, ocular, urine and faecal samples were obtained and analysed by qu...
West Nile Virus in Horses as a Sentinel Host in One Health Surveillance: Epidemiological Insights and Future Perspectives. West Nile virus (WNV) is a globally distributed mosquito-borne flavivirus with significant implications for both veterinary and public health. While horses are incidental dead-end hosts, their epidemiological role extends beyond clinical disease, as they can serve as effective sentinel hosts for detecting local viral circulation. Their frequent exposure to mosquito vectors, ability to mount measurable antibody responses, geographic stability, accessibility for monitoring, and the possibility of observation within managed owner-veterinarian systems make them particularly suitable for surveillan...
Molecular prevalence of equine herpesvirus type 1 and equine herpesvirus type 4 in thoroughbred and Arabian horse facilities in Türkiye. Equine herpesvirus-1 and -4 are contagious viruses causing respiratory disease and reproductive losses in horses. This study aimed to determine the prevalence of EHV-1 and EHV-4 in eight Turkish stud farms using RT-PCR analysis of nasal secretions, uterine fluids and aborted foal tissues. Deep nasal swabs were collected from 443 horses showing acute-onset fever and/or clinical signs of respiratory disease. Additionally, uterine swabs and tissue samples (lung, liver, spleen, thymus, kidney, heart) were obtained from 152 abortion cases. Among symptomatic horses, EHV-1 DNA was found in 2 cases (0...
Cross-protective effect of a multicomponent fusion protein vaccine during a natural episode of Streptococcus zooepidemicus respiratory disease in ponies. Streptococcus equi subspecies zooepidemicus is a highly diverse opportunistic pathogen of horses, associated with respiratory disease and endometritis. Objective: To characterise S. zooepidemicus isolates recovered from young ponies during a natural episode of respiratory disease, and to determine if vaccination with Strangvac®, a vaccine against Streptococcus equi subspecies equi, conferred cross-protection. Methods: Retrospective analysis of a double-blinded placebo-controlled study involving 32 ponies (16 vaccinates and 16 placebo controls) that experienced a natural episode of respiratory...
An epizootic of equine viral arteritis at a Thoroughbred racetrack in Illinois: 223 cases. An epizootic of equine viral arteritis (EVA) occurred over an 8-wk period in the summer of 1993 at a midwestern Thoroughbred (TB) racetrack that ceased operations in 2021. Based on clinical signs, viral isolation, and serology, 223 horses (213 TBs, 10 lead ponies) were affected. Consistent clinical signs included fever (38.3-40.6°C; 101-105°F), depression, inappetence, and diffuse urticaria, including distal limb and preputial edema. Equine arteritis virus (EAV) was cultured from buffy coat samples from 24 of 28 acutely ill horses. Seventeen of 18 convalescent horses and 1 of 92 non-affected...
Multivalent Disabled Infectious Single Animal (DISA)-DIVA vaccine for all nine serotypes of African horse sickness virus (AHSV) is broadly protective in IFNAR (-/-) mice. African horse sickness (AHS) is a highly severe, midge-borne disease of equids showing a mortality rate of > 90% in naive domestic horses. Outbreaks are caused by AHS virus (AHSV) and result in devastating economic losses in developing countries as equids play a crucial role in the agricultural industry and many households. The AHSV species encompasses nine serotypes showing no or limited cross protection, which is challenging regarding AHS vaccine development. Recently, and like bluetongue virus (BTV), the AHS Disabled Infectious Single Animal (DISA)-DIVA vaccine platform was developed...
Synthetic progestin treatment alters cytokine expression and impairs vaccine response in horses. Altrenogest is commonly used in equine veterinary medicine for the control of estrus, behavioral modifications, and maintenance of pregnancy. Recent studies have found that altrenogest may impact aspects of the immune system, including altering cytokine production in circulation and within the reproductive tract. Therefore, we hypothesize that this alteration may lead to a deviated immune response to vaccination. Sixteen mares were divided into two groups, with ten mares (n = 10) receiving long-acting injectable altrenogest (100 mg/mL; IM) administered every 10 days, and six mares (n =...
The 2025 outbreak of equine influenza among draft horses at Obihiro Racecourse, Hokkaido, Japan. In 2025, an outbreak of equine influenza occurred among draft horses at Obihiro Racecourse in Hokkaido, Japan. The number of horses showing clinical signs increased dramatically in April. The proportion affected was significantly higher in 2-year-olds than in older groups. The proportion that developed fever during the outbreak was significantly higher than that observed among Thoroughbreds during the 2007 outbreak. In non-epidemic periods, the geometric mean hemagglutination inhibition antibody titer of 2-year-old draft horses was significantly lower than that of 2-year-old Thoroughbreds. The...
What happened after the epidemic? Equine influenza surveillance sheds light on sources and seasonal risk in the United Kingdom. The epidemiology of equine influenza (EI) in the United Kingdom has not been systematically described since the 2019 epidemic. Objective: To summarise UK EI surveillance (2020-2024), quantify outbreak seasonality and assess movement-related sources. Methods: Retrospective observational analysis of national surveillance and horse importation data. Methods: Epidemiological data for laboratory-confirmed EI cases in the United Kingdom were collated. Outbreaks (EI-infected premises) were defined as one or more laboratory-confirmed cases on the same premises within a 4-week period. Monthly outbreak ...
Gaps Between Awareness and Prevention of West Nile Virus Among Horse Owners in an Endemic Country: A Cross-Sectional Study from Romania. West Nile virus (WNV) circulates endemically in Romania, yet prevention of WNV infection in horses largely depends on owner-driven decisions that require accurate risk perception and veterinary guidance. A cross-sectional online survey was carried out between May and November 2025 to evaluate the knowledge, attitudes, and preventive practices (KAP) regarding WNV among 227 horse owners from various Romanian regions. In total, 67.4% of respondents had previously heard of WNV. The main transmission route was correctly identified as mosquito bites by 49.8% of participants, while 32.2% answered "do...
Vaccination-associated lameness in warmblood horses after intramuscular injection. Intramuscular vaccination is a routine component of equine medicine, but local muscle soreness may transiently affect gait symmetry. Objective data on vaccination-associated gait changes in horses are lacking. Objective: To investigate whether intramuscular vaccination induces measurable gait asymmetries depending on injection site, to inform recommendations on vaccination site selection and short-term exercise management. Methods: In this prospective, randomised, blinded, placebo-controlled study, eighteen clinically sound Warmblood horses were enrolled and received an intramuscular vaccinati...
Molecular characterization and phylogeography of equine influenza virus H3N8 detected in donkeys in Nigeria 2022-2023. Equine influenza virus (EIV) H3N8 is a highly contagious respiratory pathogen that poses significant health and economic risks to equids globally. In southeastern Nigeria where equids are sold and slaughtered, limited data exist on EIV epidemiology and circulating lineages. Methods: To address this gap, an active surveillance was conducted between January 2022 and October 2023. A total of 400 nasal swabs were collected from horses and donkeys at slaughterhouses and animal markets. The swabs were screened for equine influenza virus (EIV) using quantitative Reverse-Transcription Polymerase Chain...
Molecular prevalence of equine alphaherpesvirus-1 shedding in healthy broodmares in Ontario. Equine herpesvirus-1 (EHV-1) is ubiquitous in the horse population, but prevalence estimates have ranged from 3 to 88% depending on the population and method of sampling. No prevalence studies have been carried out in Ontario, Canada. The objective of this study was to measure the prevalence of EHV-1 shedding in healthy broodmares in Ontario. A total of 381 mares from 42 farms in Ontario were sampled, including pregnant and barren broodmares. Samples were collected from the nose, vagina, and blood of each mare up to 6 times from December 2016 through October 2017 using a cross-sectional study ...
Closing the Stable Door on Strangles: Serological Responses of Vaccinated Horses on a Farm Following the Arrival of a New Horse. Infection of susceptible horses with subspecies (), the causative agent of strangles, is associated with commingling. Exposure may occur among horses at equestrian events, sales, or horses moved among different equine stabling environments. Strangles can affect all horses on a farm, leading to the death of up to 10% of cases depending on their immunity status at the time of infection, the development of complications, the success of biosecurity measures, and the use of vaccination. The current retrospective study used ELISAs to measure the exposure of horses to at a farm that experienced an...
Reining in strangles: Absence of disease in horses vaccinated with a DIVA-compatible recombinant fusion protein vaccine, Strangvac, following natural exposure to Streptococcus equi subspecies equi. Strangles, caused by Streptococcus equi subspecies equi (S. equi), is a prevalent infectious disease of horses. This is the first report on the use of a new vaccine, Strangvac, in a natural outbreak of strangles. Objective: To measure the effects of Strangvac vaccination during an outbreak of strangles at a Swedish farm. Methods: Longitudinal cohort study. Methods: Healthy horses (n = 17) were vaccinated on day 0, which occurred 23 days after strangles was first confirmed in three unvaccinated horses on the same farm. Blood serum samples were collected on day 0, day 28 and day 489. A com...
Neutralisation of the Immunoglobulin-Cleaving Activity of Streptococcus equi Subspecies equi IdeE by Blood Sera from Ponies Vaccinated with a Multicomponent Protein Vaccine. subspecies () is the cause of strangles, one of the most prevalent diseases of horses worldwide. The disease is characterised by fever and the formation of abscesses in the lymph nodes of the head and neck, which can restrict the airway. A multicomponent subunit vaccine, Strangvac, has been shown to effectively reduce clinical signs of strangles and to reduce its incidence. The aim of this study was to determine the immune response against the immunoglobulin-cleaving endopeptidase IdeE, a key protective component within the vaccine and the ability of antibodies to neutralize the proteolytic...
Vaccination against Hendra virus of previously unvaccinated mares and their foals demonstrates the effectiveness of the current prime and boost vaccination schedule for foals. Hendra virus (HeV) is a high consequence pathogen that causes severe respiratory and/or neurological disease in both horses and humans with high mortality. The equine vaccine, Equivac® HeV, is a recombinant soluble version of the G glycoprotein of HeV (HeV-sG) that elicits a potent HeV-neutralising antibody response in adult horses and also provides indirect protection for humans. Maternally derived HeV-G specific antibodies could interfere with subsequent foal vaccination, although other factors such as foal age and the suitability of vaccination protocols that have been optimised for adult ...
The Viremic Phase and Humoral Immune Response Against African Horse Sickness Virus That Emerged in Thailand in 2020. African horse sickness (AHS), a life-threatening disease caused by African horse sickness virus serotype 1 (AHSV-1), emerged in Thailand in February 2020 with 607 cases and a 93% fatality rate. The outbreak was mitigated by vector control and a live attenuated virus (LAV) vaccine. Information regarding viremia and immunity after infection and vaccination during outbreaks are essential for controlling disease transmission. This study evaluated these parameters in 15 infected naïve horses and 11 vaccinated horses during the 2020 outbreak. Whole blood was collected and subjected to RT real-time ...
Anti-IL-5 Vaccination Dampens Allergen-Specific IgE Levels and Modulates IL-4 and IL-5 Th2 Cytokines in Skin Allergy of Mice and Horses. Skin allergies are among the most frequent types of allergies, where continuous investigation of the pathological immune mechanisms is required for a better understanding and a more effective treatment of the disease. In this study, we aimed to investigate the effect of interleukin (IL)-5 vaccination on allergen-specific IgE antibodies as well as T cell cytokine modulation in skin allergy using a mouse model and a naturally occurring disease in horses. Methods: Ovalbumin (OVA)-sensitized mice, as well as horses affected by equine insect bite hypersensitivity (IBH) were administered an anti-IL-...
Seroprevalence of Equine Influenza Virus Antibodies in Horses from Four Localities in Colombia. Equine influenza is a highly contagious disease caused by the equine influenza virus (EIV). The occurrence of EIV outbreaks in America is associated with low levels of vaccination coverage. In Colombia, no seroprevalence evaluation has been carried out to estimate the distribution of the virus within the country. Our aim was to perform a sero-epidemiological survey of equine influenza infections and to identify associated risk factors in horses from four departments of Colombia. Serological testing was carried out by using an ELISA for the detection of IgG antibodies against the influenza A vi...
Serum and mucosal antibody testing to detect viral exposure in contact horses during an equine herpesvirus myeloencephalopathy outbreak. To apply equine herpesvirus type 1 (EHV-1) antibody testing in nasal swabs and serum in nonclinical horses during a naturally occurring outbreak of (EHV-1). Previous experimental EHV-1 challenge studies showed stable serum anti-EHV-1 antibody concentrations paired with rapidly increasing nasal mucosal antibodies (mucAbs) prevent EHV-1 infection, viral shedding, and cell-associated viremia. From this, we hypothesized that EHV-1 antibody testing can confirm exposure in non-clinical horses during an outbreak. Unassigned: 2 horses with neurological signs from 1 farm were admitted to an equine hosp...
Rabies in livestock in the United States (2012-2021). Rabies in livestock in the United States (US) poses a significant public health concern due to the potential for human exposure and economic losses to producers. Understanding the epidemiology of rabies in livestock supports broader One Health goals by enhancing early detection of viral incursions and protecting both animal and human health. This study assessed the epidemiology of rabies in livestock in the US from 2012 to 2021 using surveillance data reported to the National Rabies Surveillance System. A sensitivity analysis was conducted to estimate economic losses, including livestock value...
Attitudes and experiences of UK vets towards control and prevention of strangles. As part of her undergraduate research project, Cambridge vet student Katie Riley surveyed the attitudes of UK veterinarians with regard to preventing and controlling strangles, including the use of vaccination. Here, she and Fleur Whitlock, Abigail McGlennon and Richard Newton of Equine Infectious Disease Surveillance discuss her findings.
